Location

Please check the individual session for location or broadcast availability.  

Frequency

Monthly

Series Director

Mayar Al Mohajer, MD, MBA, MPH

Target Audience

Infectious disease physicians, hospitalists, pharmacists, infection preventionists, microbiologists, advanced practice providers, internal medicine residents and fellows, and other healthcare professionals involved in infection prevention and antimicrobial stewardship.

Needs Assessment

Despite increased attention to infection prevention and antimicrobial stewardship, significant variation persists in clinical practice across hospitals and among healthcare providers.  To address this inconsistency in practice, the series will focus on the latest national guidelines on infection prevention, the epidemiology and management of multidrug-resistant organisms and emerging pathogens, and advances in rapid diagnostics, resistance surveillance, and implementation science.  It will also enhance competence in the application of clinical guidelines to diverse patient populations, the interpretation of antibiograms and microbiology reports, and the use of behavioral science principles to implement and sustain infection prevention and antimicrobial stewardship practices.  The series aims to improve compliance with evidence-based infection-prevention bundles and audit-feedback programs, prescribing practices, and communication and decision-making around isolation precautions, diagnostic testing, and antimicrobial use.

Educational Methods

Educational methods will include lectures, case presentations, literature review, panel discussion, and audience response..

Objectives

At the conclusion of the sessions, the participants should be able to:

• Describe the latest evidence-based guidelines and core strategies for preventing healthcare-associated infections (HAIs) and implementing effective antimicrobial stewardship programs.
• Demonstrate the ability to interpret and apply clinical microbiology data, local antibiograms, and rapid diagnostic test results to optimize antibiotic selection, dosing, and duration for common infections.
• Implement data-driven interventions such as audit feedback, diagnostic stewardship, and device utilization reviews at the institution level to reduce unnecessary antibiotic use and lower rates of central line-associated bloodstream, catheter-associated urinary tract, and surgical site infections and infections with Clostridioides difficile and multidrug-resistant organisms.

Evaluation

Participants may be asked to complete a session evaluation.

Accreditation/Credit Designation

Baylor College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Baylor College of Medicine designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Series Coordinator